N Mitsiades Selected Research

N Mitsiades Research Topics

Disease

8	Neoplasms (Cancer) 01/2016 - 01/2001
4	Multiple Myeloma 03/2004 - 05/2001
3	Thyroid Neoplasms (Thyroid Cancer) 08/2003 - 08/2000
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2016 - 06/2001
2	Ewing Sarcoma (Sarcoma, Ewing) 08/2001 - 03/2001
2	Neuroblastoma 06/2001 - 05/2001
2	Graves Disease (Basedow Disease) 09/2000 - 07/2000
1	Prostatic Intraepithelial Neoplasia 01/2017
1	Adenocarcinoma 01/2017
1	Disease Progression 01/2016
1	Thyroiditis 11/2001
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 05/2001
1	Paraproteinemias (Monoclonal Gammopathy) 05/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2001
1	Thyroid Diseases (Thyroid Disease) 09/2000
1	Papillary Thyroid Cancer 09/2000
1	Medullary Carcinoma 08/2000
1	Carcinoma (Carcinomatosis) 08/2000
1	Papillary Carcinoma 08/2000
1	Inflammation (Inflammations) 01/2000

Drug/Important Bio-Agent (IBA)

4	LigandsIBA 08/2003 - 08/2000
4	Fas Ligand Protein (Fas Ligand)IBA 06/2001 - 07/2000
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2001
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2003 - 08/2000
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2001 - 01/2001
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2016
2	fas Receptor (CD95 Antigen)IBA 11/2001 - 06/2001
2	Pharmaceutical PreparationsIBA 06/2001 - 01/2001
2	Caspase 8 (Caspase-8)IBA 06/2001 - 08/2000
2	CaspasesIBA 06/2001 - 08/2000
2	Matrix Metalloproteinases (MMPs)IBA 06/2001 - 01/2001
1	GlucocorticoidsIBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Proteasome InhibitorsIBA 03/2004
1	Bortezomib (Velcade)FDA Link 03/2004
1	2-MethoxyestradiolIBA 03/2004
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2004
1	CytokinesIBA 08/2003
1	SteroidsIBA 08/2001
1	Cytochromes c (Cytochrome c)IBA 06/2001
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 06/2001
1	Antisense OligonucleotidesIBA 06/2001
1	DNA (Deoxyribonucleic Acid)IBA 06/2001
1	Cytotoxins (Cytolysins)IBA 06/2001
1	Antineoplastic Agents (Antineoplastics)IBA 06/2001
1	Muscarinic AgonistsIBA 05/2001
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2001
1	GTP-Binding Proteins (G-Protein)IBA 05/2001
1	Carbachol (Carbastat)FDA Link 05/2001
1	AntigensIBA 05/2001
1	Complement System Proteins (Complement)IBA 05/2001
1	Rituximab (Mabthera)FDA Link 05/2001
1	Monoclonal AntibodiesIBA 05/2001
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 03/2001
1	Complementary DNA (cDNA)IBA 01/2001
1	AntibodiesIBA 09/2000
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 09/2000
1	Cycloheximide (Cicloheximide)IBA 08/2000
1	Protein Synthesis InhibitorsIBA 08/2000
1	Indicators and Reagents (Reagents)IBA 08/2000
1	Caspase 10IBA 08/2000
1	IodidesIBA 07/2000
1	AutoantibodiesIBA 07/2000
1	NF-kappa B (NF-kB)IBA 01/2000
1	CarrageenanIBA 01/2000
1	caffeic acid phenethyl esterIBA 01/2000

Therapy/Procedure

5	Therapeutics 03/2004 - 05/2001
3	Drug Therapy (Chemotherapy) 08/2001 - 01/2001
1	Biological Therapy 08/2001